Heterocyclic derivatives as gpcr receptor agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/04 (2006.01) A61K 31/4245 (2006.01) C07D 413/06 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2549955

Compounds of Formula (I), R1-A-V-B-R2; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.

Selon l'invention, des composés de formule R?1¿-A-V-B-R?2¿ (I) ou des sels pharmaceutiquement acceptables desdits composés sont des agonistes de GPR116 et sont utiles comme régulateurs de la satiété, notamment pour le traitement de l'obésité et le traitement du diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic derivatives as gpcr receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic derivatives as gpcr receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives as gpcr receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1617077

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.